Trading Report: The Kanawha Capital Management LLC Holds Stake in UnitedHealth Group Inc. (UNH)

The Kanawha Capital Management LLC Holds Stake in UnitedHealth Group Inc. (UNH)

Kanawha Capital Management LLC held its stake in UnitedHealth Group Inc. (NYSE:UNH) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,071 shares of the healthcare conglomerate’s stock at the end of the second quarter. Kanawha Capital Management LLC’s holdings in UnitedHealth Group were worth $292,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. Picton Mahoney Asset Management increased its stake in UnitedHealth Group by 2,569.7% in the first quarter. Picton Mahoney Asset Management now owns 162,852 shares of the healthcare conglomerate’s stock valued at $20,991,000 after buying an additional 156,752 shares during the last quarter. Investec Asset Management LTD increased its stake in UnitedHealth Group by 0.4% in the first quarter. Investec Asset Management LTD now owns 2,356,685 shares of the healthcare conglomerate’s stock valued at $303,777,000 after buying an additional 9,202 shares during the last quarter. Investec Asset Management North America Inc. increased its stake in UnitedHealth Group by 40.1% in the first quarter. Investec Asset Management North America Inc. now owns 15,934 shares of the healthcare conglomerate’s stock valued at $2,054,000 after buying an additional 4,562 shares during the last quarter. King Wealth Management Group LLC increased its stake in UnitedHealth Group by 2.1% in the first quarter. King Wealth Management Group LLC now owns 9,550 shares of the healthcare conglomerate’s stock valued at $1,231,000 after buying an additional 200 shares during the last quarter. Finally, Aviva PLC increased its stake in UnitedHealth Group by 1.5% in the first quarter. Aviva PLC now owns 541,398 shares of the healthcare conglomerate’s stock valued at $69,786,000 after buying an additional 8,018 shares during the last quarter. Institutional investors and hedge funds own 85.80% of the company’s stock.

UnitedHealth Group Inc. (NYSE:UNH) traded up 0.20% on Monday, hitting $134.19. The stock had a trading volume of 2,321,448 shares. The company’s 50-day moving average price is $137.02 and its 200 day moving average price is $136.52. UnitedHealth Group Inc. has a one year low of $107.51 and a one year high of $144.48. The firm has a market cap of $127.80 billion, a price-to-earnings ratio of 21.00 and a beta of 0.57.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Friday, September 9th were given a dividend of $0.625 per share. The ex-dividend date was Tuesday, September 6th. This represents a $2.50 annualized dividend and a dividend yield of 1.87%. UnitedHealth Group’s dividend payout ratio is currently 39.12%.

UNH has been the topic of several research analyst reports. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, June 21st. Leerink Swann reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Monday, June 27th. Wolfe Research began coverage on UnitedHealth Group in a research note on Tuesday, June 28th. They set an “outperform” rating and a $172.00 price target on the stock. Credit Suisse Group AG restated a “buy” rating and issued a $148.00 target price on shares of UnitedHealth Group in a research note on Wednesday, June 29th. Finally, Sanford C. Bernstein began coverage on UnitedHealth Group in a research note on Friday, July 15th. They issued an “outperform” rating on the stock. One investment analyst has rated the stock with a hold rating, twenty-five have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $155.35.

In related news, Director Richard T. Burke sold 40,000 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the completion of the transaction, the director now directly owns 2,003,550 shares in the company, valued at approximately $271,100,350.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.65% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Related posts

Leave a Comment